Navigation Links
Biosensors Reports Financial Results for the Second Quarter and First Half of Fiscal Year 2014
Date:11/12/2013

SINGAPORE, Nov. 12, 2013 /PRNewswire/ -- Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, today announced financial results for the second quarter of its Fiscal Year 2014 (Q2 FY14) and first half ended 30 September 2013 (H1 FY14).

Second Quarter Highlights and Recent Developments:

  • Growth in total revenue and product revenue both improved compared to the first quarter of Fiscal Year 2014 (Q1 FY14). Total revenue grew 4% year-over-year and 8% sequentially, while total product revenue increased 10% and 11%, respectively.
  • The EMEA and APAC regions continued to lead drug-eluting stent (DES) sales growth with double digit sales volume growth
  • China sales improved following inventory reduction in the first quarter
  • Obtained various significant regulatory approvals, including:
    • Therapeutic Goods Administration (TGA) approval for BioMatrix Flex™ in Australia
    • CE Mark for expanded size of Axxess™ (4.0 x 9 mm extension)
    • CE Mark for drug-eluting balloons (DEBs) – BioPath™ 014 and BioPath™ 035 for the treatment of peripheral arterial disease and BioStream™ for the treatment of coronary artery disease
    • China Food and Drug Administration (CFDA) approval for Spectrum Dynamics' ("SD") D-SPECT Cardiac Imaging System
  • Final results from landmark LEADERS trial published in JACC Cardiovascular Interventions

"In the second quarter, we achieved better results than the first quarter. Our total revenue growth increased sequentially, as the decline in our royalty income began to moderate. We continued to achieve double digit sales volume
'/>"/>

SOURCE Biosensors International Group, Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2014
2. Biosensors Reports Financial Results for Fiscal Year 2013
3. Biosensors Completes Spectrum Dynamics Assets Acquisition
4. Biosensors to Acquire Assets of Spectrum Dynamics
5. Frost & Sullivan Acknowledges that PKCs Biosensors are Expected to Become the New Industry Standard in Pathogen Testing
6. Biosensors Reports Financial Results for the Third Quarter of Fiscal Year 2013
7. Biosensors Reports Strong Sales and Profitability in the First Quarter of Fiscal Year 2013
8. Mirati Therapeutics Reports Third Quarter 2013 Financial Results
9. BioSpecifics Technologies Corp. Reports Third Quarter 2013 Financial Results
10. Celsion Corporation Reports Third Quarter 2013 Financial Results and Provides Business Update
11. Soligenix Reports Third Quarter 2013 Financial Results, and Highlights Recent Accomplishments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)...  SI-BONE, Inc., a medical device company that pioneered ... the sacroiliac (SI) joint with the iFuse Implant System ... have now been performed world wide utilizing more than ... iFuse procedure continues to grow and gain momentum with ... the United States and 17 countries ...
(Date:3/2/2015)... BETHESDA, Md. , March 2, 2015  Celimmune ... and preventing autoimmune diseases, announced today that it has ... from Amgen (NASDAQ: AMGN ). Under the ... rights to develop, manufacture and commercialize AMG 714 on ... Concurrently, Amgen has been granted an exclusive option to ...
(Date:3/2/2015)... ANGELES , March 2, 2015 ImmunoCellular Therapeutics, Ltd. ... financial results for the year ended December 31, 2014 on March ... conference call and webcast on Thursday, March 12, 2015, at 5:00 ... , President and CEO.   , ... dial-in: (631) 291-4544; conference code 92238648. , , , ...
Breaking Medicine Technology:SI-BONE, Inc. Announces 15,000 iFuse Procedure Milestone 2SI-BONE, Inc. Announces 15,000 iFuse Procedure Milestone 3Celimmune Announces Anti-IL-15 Antibody Licensing and Option Agreements with Amgen 2Celimmune Announces Anti-IL-15 Antibody Licensing and Option Agreements with Amgen 3ImmunoCellular Therapeutics to Report 2014 Financial Results on March 9, 2015; a Business Update Conference Call and Webcast is Scheduled for March 12, 2015 2
... JOSEPH, Mo., April 14, 2011 On Monday, April ... Veterinary cardiologists on the Mobile Dog Heart Health Tour ... free dog heart examinations at Seger Dog Park. ... to providing free heart health screenings, veterinarians will be ...
... GlaxoSmithKline (GSK) is committed to ensuring that consumers and ... alli is safe and effective when used as directed. ... locally in the gastro-intestinal tract. GSK continues to proactively ... relevant information with regulatory agencies. Since orlistat ...
Cached Medicine Technology:Veterinarians to Perform Free Dog Heart Health Screenings in Philadelphia on April 18 2Veterinarians to Perform Free Dog Heart Health Screenings in Philadelphia on April 18 3
(Date:3/2/2015)... 2015 After a rigorous evaluation process ... pricing and long-term strategy, Blood Centers of America (BCA) ... for member centers’ testing needs. , BCA, which comprises ... than 30 percent of the U.S. blood supply, made ... is committed to drive cost savings to members,” said ...
(Date:3/2/2015)... March 02, 2015 Representatives with ... has officially launched a multivitamin supplement that’s specifically ... product development for BNatrl, said the multivitamin, which ... Olympic and other world-class athletes. , "Being an ... this pure whole food multivitamin to improve my ...
(Date:3/2/2015)... Washington, DC (PRWEB) March 02, 2015 ... the publication of AIS’s Directory of Health Plans: ... comprehensive resource available on the U.S. health plan market, ... operating in the United States. , Available as ... “Executive Summary” of enrollment trends in quick-view tables and ...
(Date:3/2/2015)... What are the best practices for writing ... are interviews scheduled, how can physicians best prepare, and ... practicing physicians who are looking for new opportunities can ... the PracticeLink Physician Career Advancement Workshop and Job Fair ... from 5:30 to 8:30 p.m. at the Marriott-Texas Medical ...
(Date:3/2/2015)... Final Cut Pro X plugin specialists have ... Film Studios. , “The TranStatic Volume 2 plugin gives users ... CEO of Pixel Film Studios. “TranStatic Volume 2 is a ... editors toolbox.” , With TranStatic Volume 2 users can transition ... scrambling effects from Pixel Film Studios. Users have total control ...
Breaking Medicine News(10 mins):Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 2Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 3Health News:Bnatrl Launches Multivitamin Supplement for Runners 2Health News:Now Available from AIS: 12th Edition of Annual Book Containing Health Plan Enrollment Data, Contact Information 2Health News:PracticeLink to Host a Career Advancement Workshop and Job Fair in Houston 2Health News:Pixel Film Studios released the TranStatic Volume 2 plugin for Final Cut Pro X today 2
... , HOUSTON , Feb. 8 Runners and ... to visit the NASA Goes the Distance exhibit this Friday and ... Palmer Event Center. NASA,s exhibit will be open from 3 ... to 6 p.m. Saturday . The exhibit will be located in ...
... matter unless father was older, mom much younger, study found ... more likely to have a child with autism than women ... , Researchers from University of California, Davis, looked at records ... and 1999, a decade in which autism incidence increased 600 ...
... ... Shawn Strash, FACHE, Chief Executive Officer with Oro Valley Hospital, on critical issues facing ... ... foster timely communication among different segments of the medical community, Jackson & Coker ( ...
... , , , , , ... Feb. 8 /PRNewswire-Asia-FirstCall/ -- Renhuang,Pharmaceuticals, Inc. (Pink Sheet: ... botanical products,bio-pharmaceuticals and traditional Chinese medicines ("TCM"), announced today,that it ... fiscal year ended, October 31, 2009 on time. In ...
... ... joins StatCom in a strategic partnership program that helps hospitals transform throughput operations. ... Atlanta, GA (PRWEB) ... MSN, FACHE, a former Trident Health System executive, to the StatCom transformation team as ...
... limiting TV and getting enough sleep cut risk of obesity, ... as simple as sitting down to dinner together as a ... fend off obesity. , That,s just one of the findings ... a significant impact on the weight of preschool children. Other ...
Cached Medicine News:Health News:NASA Joins Austin Marathon Expo, Inspires Students 2Health News:Older Moms More Apt to Have Autistic Child 2Health News:Older Moms More Apt to Have Autistic Child 3Health News:Jackson & Coker Industry Report Spotlights Healthcare Executive Interview, 2Health News:Jackson & Coker Industry Report Spotlights Healthcare Executive Interview, 3Health News:Jackson & Coker Industry Report Spotlights Healthcare Executive Interview, 4Health News:Jackson & Coker Industry Report Spotlights Healthcare Executive Interview, 5Health News:Jackson & Coker Industry Report Spotlights Healthcare Executive Interview, 6Health News:Renhuang Reports Record Fiscal 2009 Results; Resumes Compliance With SEC Filing Requirements 2Health News:Renhuang Reports Record Fiscal 2009 Results; Resumes Compliance With SEC Filing Requirements 3Health News:PJ Johnson Joins StatCom as Enterprise VP, Southeast Region 2Health News:PJ Johnson Joins StatCom as Enterprise VP, Southeast Region 3Health News:3 Home Habits Help Youngsters Stay Slim 2Health News:3 Home Habits Help Youngsters Stay Slim 3
... TBR-40 is a small bench style refrigerator (can ... only a minimum number of bags is to ... External cabinet finish is white colorbond steel while ... closing side hinged glass door is key lockable. ...
... refrigerator is specially designed ... blood in standard 500ml ... Standard AS3864 1997. Quiet ... utilising CFC Free refrigerant ...
The Testosterone Enzyme Immunoassay is intended for the quantitative determination of Testosterone concentration in human serum. No special pretreatment of the sample is necessary. For in vitro Diag...
The Testosterone ELISA is intended for the quantitative determination of testosterone concentration in human serum. No special pretreatment of the sample is necessary....
Medicine Products: